Comparative pathophysiology and pathology of transient ischemic attack, ischemic stroke, and reperfusion injury: Mechanistic and therapeutic perspectives
Pathology - Research and Practice · 2026-10 · 286 · 156606
DOI: 10.1016/j.prp.2026.156606 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2026-10. Verfasst von Ji Hyeon Ahn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Therapy, College of Health Science, Youngsan University, Yangsan 50510, Republic of Korea. Electronic address: jh-ahn@ysu.ac.k…. Hauptthemen laut MEDLINE: Ischemic Attack, Transient, Reperfusion Injury, Ischemic Stroke. Die Arbeit nennt 114 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Transient ischemic attack (TIA), ischemic stroke, and ischemia-reperfusion (IR) injury represent a continuum of cerebrovascular disorders with distinct clinical and pathophysiological features. While TIA is classically considered benign, recent studies reveal subtle yet potentially deleterious neuronal and glial changes. Ischemic stroke typically results in sustained hypoperfusion, infarction, blood-brain barrier (BBB) disruption, and robust neuroinflammatory cascades. IR injury, though potentially beneficial through vessel recanalization, paradoxically induces oxidative stress, cytokine release, and secondary infarction. This review systematically compares the molecular, histological, and behavioral profiles of these three conditions. Key differences include patterns of neuronal death, glial activation, oxidative damage, and BBB integrity. Human neuroimaging data and animal model histology are integrated to illustrate characteristic features across the spectrum. We also discuss current experimental models and their translational relevance, highlighting challenges in modeling comorbidities and chronic outcomes. Precision medicine strategies considering sex, age, and immune background-are emphasized as essential for advancing diagnostics and optimizing therapeutic efficacy. Emerging multimodal therapies, including pharmacological agents, stem cells, gene editing, and nanomedicine, hold promise but require rigorous validation. A deeper mechanistic understanding of each condition will be crucial for tailoring treatment strategies and bridging the translational gap in ischemic cerebrovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physical Therapy, College of Health Science, Youngsan University, Yangsan 50510, Republic of Korea. Electronic address: jh-ahn@ysu.ac.kr.
- Department of Emergency Medicine, School of Medicine, Kangwon National University, Chuncheon 24341, Republic of Korea. Electronic address: mhwon@kangwon.ac.rk.
Zitieren
APA
Ahn, J. H., & Won, M. H. (2026). Comparative pathophysiology and pathology of transient ischemic attack, ischemic stroke, and reperfusion injury: Mechanistic and therapeutic perspectives. Pathology - Research and Practice, 286, 156606. https://doi.org/10.1016/j.prp.2026.156606
Vancouver
Ahn JH, Won MH. Comparative pathophysiology and pathology of transient ischemic attack, ischemic stroke, and reperfusion injury: Mechanistic and therapeutic perspectives. Pathology - Research and Practice. 2026;286:156606. doi:10.1016/j.prp.2026.156606
BibTeX
@article{Ahn2026,
author = {Ahn, Ji Hyeon and Won, Moo-Ho},
title = {Comparative pathophysiology and pathology of transient ischemic attack, ischemic stroke, and reperfusion injury: Mechanistic and therapeutic perspectives},
journal = {Pathology - Research and Practice},
year = {2026},
volume = {286},
pages = {156606},
doi = {10.1016/j.prp.2026.156606}
}
EUVIMED